Approximately 76,000 discovered makes terpenoids the largest family of natural 12 products in nature with widespread applications. The wide-spectrum of structural diversity of the 13 terpenoids were largely due to the variable skeletons generated by terpene synthases. The 14 number of terpene skeletons found in nature, however, were so much more than those 15 conceivably generated from known terpene synthases and the limited characterized terpene 16 synthases also make no chance for some useful terpenoids overproduction in microbe. Here, we 17 first demonstrated that the promiscuous synthases in vivo can produce more variable terpenoid 18 products by converting precursors of different lengths (C 10 , C 15 , C 20 , C 25 ). This discovery was 19 prompted by the development of an efficient in vivo platform by combining the two promiscuous 20 terpene synthases and three prenyltransferases to generate 50 terpenoids, at least 3 ring systems 21 of which were completely new. Furthermore, protein engineering was further integrated to 22 enhance product diversity. Clearly, the work is expected to dramatically reshape the terpenoid 23 research by widening the flexibility of the terpene synthases for the fresh discovery or creation of 24 the new terpenoid compounds by skeleton reframing. 25
Introduction
cyclise these polyisoprenoid diphosphates to generate terpene products with a single ring or 48 intricate multiple rings (Christianson, 2006) ; (iii) tailoring enzymes, including oxygenases, 49 methyltransferases, acetyltransferases, and glycosyltransferases, add functional groups at 50 different positions, further enhancing structural diversity. The possibility of obtaining linear products from the first step is very limited for the fixed length of C 5 precursors, and the 52 flexibility of the final products from the third step strongly depends on the skeletons from the 53 second step. Thus, variability in the skeleton is mainly introduced through the cyclisation step. 54
Biosynthesis by terpene synthases in this step has inherent advantages over chemical synthesis 55 (Maimone and Baran, 2007) ; however, the biosynthetic repertoire identified to date only covers a 56 small proportion of the terpene skeletons discovered, which only covers a small proportion of 57 potential terpene skeletons through theoretical calculations (Tian et al., 2016) . Additionally, most 58 traditional methods to investigate terpene synthases only focus on their major functions under 59 native conditions, ignoring their potential for different applications. 60
Combinatorial biosynthesis of terpenoid skeletons will be an effective solution when two 61 prerequisites are satisfied: identification of terpene synthases that tolerate different lengths of 62 isoprene-diphosphate as substrates, and generation of suitable polyisoprenoid diphosphate 63 substrates for these enzymes. In this study, we successfully identified promiscuous terpene 64 synthases in nature and developed a terpene-overproducing chassis to satisfy these two criteria.
nonconserved residues in the active-site cavity were generated using the WebLogo server 99 (http://weblogo.berkeley.edu/). 100
Molecular modeling 101
The three-dimensional model of the TC domain of FgMS was built using the SWISS-102 MODEL web server (https://www.swissmodel.expasy.org/). The crystal structure of the TC 103 domain of PaFS from Phomopsis amygdali was selected as the template. The resulting homology 104 structures were visualised using UCSF Chimera. 105
In vitro assays and kinetic measurements 106
To test the in vitro activities of FgMS, its mutants, and FgGS, reactions were conducted 107 using 10 μM purified proteins, 100 μM substrates (GPP, FPP, GGPP, or GFPP), and 2 mM Mg 2+ 108 in 200 μL of 50 mM PB buffer (pH 7.6) with 10% glycerol at 30°C overnight. The sample was 109 extracted with hexane (200 μL) and then analysed by GC-MS. For steady-state kinetics, 100-μL 110 scale reactions were carried out in 50 mM Tris-HCl buffer (pH 7.6) with 10% glycerol and 50 μL 111 pyrophosphate reagent. The concentration of the enzyme (FgMS or FgGS) were kept constant at 112 containing 1 L LB medium at 37°C with 100 mg/L ampicillin (AMP), 50 mg/L KAN, and 34 mg/L chloramphenicol (CM). When the OD 600 reached 0.6-0.8, 0.1 mM IPTG was added to the 122 cultures, protein expression was induced at 16°C for 18 h, and the strains were then cultivated at 123 28°C for an additional 3 days. The cell cultures were extracted twice with an equal volume of 124 hexane. The organic layer was concentrated using a rotary evaporator, and terpenoids were 125 purified using a Dionex Ultimate 3000 UHPLC system. 126
Detection of terpenoids 127
Terpenoids were extracted by hexane and detected by GC-MS (Thermo TRACE GC ULTRA  128 combined with a TSQ QUANTUM XLS MS). The samples were injected into a TRACE TR-129 5MS (30 m × 0.25 mm × 0.25 um). The oven temperature was set at 80°C for 1 min, increased to 130 220°C at a rate of 10°C/min, and held at 220°C for 15 min. The injector and transfer lines were 131 maintained at 230°C and 240°C, respectively. Product structures were determined by comparison 132 with authentic standards, comparison with mass spectra data from the NIST library, and NMR 133 analysis. 134
Results 135

Terpene synthases with substrate promiscuity 136
To predict promiscuous terpene synthases from sequences, we collected sequences of terpene 137 synthases in fungi, a major source of terpenoids that has not yet been fully explored, and 138 constructed a phylogenic tree. Fifty-one genetically or biochemically characterised terpene 139 synthases (Additional Data Table S1), including mono-, sesqui-, di-, and sesterterpene synthases, 140 were mainly divided into five clades ( Fig. 1a ). One of them, clade III, was the most interesting. 141
Notably, as of the writing of this manuscript (August 2016), all characterised di-and 142 sesterterpene synthases in fungi were enriched in clade III rather than widely distributed, while (Dickschat, 2016; Yamada et al., 2015) . Thus, enzymes in this clade are more likely to generate 145 large complex terpene skeletons ( Fig. 1b ). More importantly, in this clade, three enzymes are 146 able to catalyse the cyclisation of multiple polyisoprenoid diphosphate substrates in vitro ( enzymes have not been investigated to date, we speculated that the broad substrate range could 149 be a common property of this type of terpene synthase. For these two reasons, we selected 150 enzymes in clade III as candidates for combinatorial biosynthesis. 151
From the collection of genomes we sequenced in our lab, we found two clade III terpene 152 synthases in an endophytic fungus Fusarium graminearum J1-012, a well-known pathogen 153 causing Fusarium head blight. These two enzymes (i.e., FgJ07578 and FgJ07623 in our 154 annotated genome) were selected as candidates because no similar clade III enzymes of them 155 have been characterised before. FgJ07578 is a chimeric protein consisting of an N-terminal 156 terpene cyclase (TC) domain and a C-terminal PT domain; in contrast, FgJ07623 only contains a 157 TC domain of 316 amino acids. Notably, no PT exists near FgJ07623, and the biosynthetic genes 158 in its cluster are not typically related to terpenoid synthesis ( Fig. S2 ). 159
Validating broad substrate specificities 160
These two enzymes (FgJ07578 and FgJ07623) were overexpressed in E. coli, purified, and 161 characterised biochemically in vitro. Surprisingly, in the absence of IPP, both FgJ07578 and 162
FgJ07623 could directly catalyse the conversion GPP, FPP, GGPP, and GFPP to generate 163 multiple products in vitro, as detected by gas chromatography mass spectrometry (GC-MS), 164 exhibiting unprecedentedly broad substrate specificities for polyisoprenoid diphosphates (Fig. 2) . itself, we also conducted in vitro experiments with the addition of IPP for FgJ07578. When 167 DMAPP and IPP were used as substrates, mono-, sesqui-, di-, and sesterterpenes were all 168 detected through in vitro reactions, indicating that the PT domain of FgJ07578 could generate 169 multiple polyisoprenoid diphosphates from C 10 to C 25 in vitro (Fig. S3 ). In addition, when GPP, 170 FPP, or GGPP was incubated with the addition of IPP as substrates ( Fig. S3 ), both terpenes with 171 corresponding lengths and terpenes with longer lengths were generated, suggesting that 172 polyisoprenoid diphosphate substrates could be not only directly cyclised by the TC domain but 173 also first elongated by the PT domain to form longer substrates. 174
We then performed kinetic analyses to understand the turnover rates and specificities 175 quantitatively. When substrates reaching their saturating concentrations, FgJ07578 exhibited 176 higher turnover rates for GGPP and GFPP (almost equally), and FgJ07623 exhibited the highest 177 turnover rate for GGPP. However, both FgJ07578 and FgJ07623 will prefer GPP as the better 178 substrate if different substrates were given, because of their highest specificity constants (k cat /K m ) 179 for GPP. Notably, the specificity constants towards FPP, GGPP, and GFPP were similar for these 180 two enzymes, with their differences being less than 1.5-fold change ( Table 2 ). This similarity 181 provided a basis for engineering to exploit substrate promiscuity by redistributing substrates in 182 vivo. 183
Combinatorial biosynthesis of terpenoid skeletons 184
To realise the full potential of these promiscuous terpene synthases, we developed a platform 185 consisting of three parts: a terpene-overproducing chassis, a PT library, and the promiscuous 186 terpene synthases of interest. First, we built an E. coli strain as a terpene-overproducing chassis 187 based on previous design principles (Zhu et al., 2014) . Specifically, on the basis of data from in ERG13, tHMG1, ERG13, ERG8, MVD1, and Idi) was appropriately constructed to provide 190 sufficient C5 precursors (Fig. 3a) . This strategy has successfully been applied to overproduction 191 of farnesene (Zhu et Three sesterterpenoids were subjected to NMR analyses, two of which were new precursors 204 of natural products with pharmaceutical activities. Specifically, two sesterterpenoid products (1 205 and 2) in E. coli T7 were identified as a 5-5-6-5 tetracyclic compound and an 11-6 bicyclic 206 compound, respectively. Compound 1 is the sesterterpene precursor of mangicols, of which 207 mangicol A and mangicol B exhibit anti-inflammatory activity (Renner et al., 2000) . Compound 208 2 is the sesterterpene precursor of variecolin, which has been shown to inhibit angiotensin II 209 receptor (Hensens et al., 1991) and act as an immunosuppressant (Fujimoto et al., 2000) . The 210 identification of these skeletons could fill gaps between biosynthetic repertoire and known natural products. The cyclisation mechanisms of these two compounds were summarised in Fig.  212 S6a according to previous classification (Ye et al., 2015) . Besides these two compounds, the GC-213 MS data ( Fig. 3c and Fig. S5 ) of another six sesterterpenoids (37 to 42) detected from E. coli T7 214 cannot be matched with existing sesterterpenoids data in the literatures, suggesting that new 215 structures could be discovered. The only sesterterpenoid product (3) in E. coli T10 was 216 determined to be 2E-alpha-cericerene; this compound is also a sesterterpene product of the EvVS 217 variant (Qin et al., 2016) , which shares only 40% sequence identity with FgJ07623. 218
From structural elucidation of diterpene products, three entirely new ring systems were 219 identified. The diterpenoid main product (4) in E. coli T8 was found to be cembrene A, a simple 220 skeleton with a large 14-membered ring that has been reported to be a byproduct of the bacterial diterpene. Compounds 9 and 10 were identified as 5-5-7-4 and 5-5-6-5 tetracyclic diterpene 231 alcohols without any double bonds, respectively. To the best of our knowledge, the 5-5-5-5, 5-5-232 6-5, and 5-5-7-4 tetracyclic skeletons are unprecedented. The absolute configuration of 10 was products (11 and 12) in E. coli T9 were validated as trans-nerolidol and 2E, 6E-farnesol, two 236 linear alcohols. E. coli T12 also produced trans-nerolidol as the main product, which is one of 237 the few overlapping products of these two terpene synthases (Fig. S7) . 238
According to existing natural products mangicol and variecolin, the new products 1 and 2 239 were designated mangicdiene and variecoltetraene respectively. Because no reference could be 240 given to new products 5 and 7 to 10, they were designated GJ1012 A to E, respectively; thus, 241 these two terpene synthases (FgJ07578 and FgJ07623) were designated F. graminearum 242 mangicdiene synthase (FgMS) and F. graminearum GJ1012 synthase (FgGS), respectively. 243
Other promiscuous terpene synthases in this clade 244
To test whether the substrate promiscuity is a widespread feature of this kind of terpene 245 synthases, we performed large scale genome mining. In UniProt database, 2088 proteins from 246 208 fungal genomes were predicted to be class I terpene synthases. According to our phylogenic 247 analysis, 321 (15.4%) of them could be further classified as clade III terpene synthases in 109 248 different species (Additional Data Table S2 ). The result indicates clade III terpene synthases are 249 easily available for application of our strategy. 250
Incorporating protein mutagenesis 251
To further enhance product diversity, we performed site-direct mutations of the promiscuous 252
FgMS as an example to integrate protein engineering into our framework. We first investigated 253 how the diverse sequence features of natural terpene synthases led to functional differentiation in 254 evolution. At least 13 noncatalytic sites within the pocket were diverse in fungi (Table S1 ). For 255 convenience, we named these specificity-determining sites (SDSs) 1-13, corresponding to 256 residue numbers 65, 69, 85, 88, 89, 159, 168, 191, 219, 222, 307, 311, and 314 in FgMS. In the tyrosine (Y) not only stabilise carbocation centres through cation-π interactions but also provide 259 steric hindrance, restricting the active-site contour (Li et al., 2014) ; therefore, we highlighted the 260 SDSs where aromatic residues occurred in the sequence logo for each clade of the phylogenetic 261 tree (Fig. 4a ). Aromatic residues in SDSs 5, 6, and 13 were relatively conserved in all fungal 262 terpene synthases; however, other SDSs with abundant aromatic residues seemed specific to 263 distinct clades, e.g., they were enriched in SDSs 1, 8, and 9 in clade III and in SDSs 2, 11, or 12 264 in other clades. Thus, based on our observations of natural evolution, our protein engineering 265 strategy focused on the interchange between aromatic and nonaromatic residues for each SDS in 266 FgMS (Fig. 4b) . 267
Our preliminary cell-free incubation experiments showed that when nonaromatic residues of 268 SDSs in FgMS were replaced by F, W, or Y, the mutants generated the same products, but with 269 different product ratios, i.e., substitutions of different aromatic residues did not alter the product 270 compositions of FgMS. Therefore, we only used the mutants replaced by F to represent the 271 interchange from a nonaromatic residue to an aromatic residue. All mutants of interchange 272 between aromatic and nonaromatic residues for SDSs maintained their catalytic activity, at least 273 for FPP (Additional Data Table S3 and Fig. 4c ). Nine of the mutants exhibited narrower 274 substrate ranges, and two of them even lost catalytic activity for GGPP (Fig. 4c) . These 275 phenomena also implied that interchange between aromatic and nonaromatic residues could be 276 utilised to broaden the substrate ranges of other terpene synthases with narrow ones. From a 277 homolog model view, when the nonaromatic hydrophobic residues were replaced by aromatic 278 hydrophobic residues in the middle or bottom of the binding pocket, the overall pocket volume 279 will be greatly reduced disabling the catalysis of longer substrates. Position A88 was an exception because it did not point to the center of the binding pocket (Fig. 4b ). Comparing the 281 sequences of characterised diterpene synthases and sesterterpene synthases could also offer 282 similar explanations. PaFS cannot accept GFPP and it possesses more aromatic residues in their 283 binding pockets (at SDS 1, 5, 6, 8, 9, and 13) (Table S1 ). 284
For the majority, the product profiles were redistributed, thus we could exploit different 285 mutants to enhance production of certain products (Additional Data Table S3 ). More importantly, 286 new products could be generated in this way to further enhance the terpene skeleton diversity. 287
For examples, six new sesterterpenoids (53 to 58) emerged from mutants F65L and F159G ( Fig.  288 4d and Fig. S5 ). Compound 56 was isolated and identified as a new 5-8-6-6 tetracyclic 289 sesterterpene ( Fig. 4e) , which has the same skeleton as asperterpenol (Xiao et al., 2013) , a fungal 290 metabolite showing inhibition on acetylcholinesterase (acetylcholinesterase inhibition is one of 291 current strategies to Alzheimer's disease). In summary, incorporating protein engineering 292 methodology boosted the performance of the combinatorial biosynthesis strategy. 293
Discussion 295
Our findings suggested that a relative small set of building blocks was sufficient to generate 296 skeletally diverse terpenoids, demonstrating the elegance of terpene biosynthesis in nature. 297
Although we did not test the physiological roles of the promiscuous terpene synthases (because 298 they were silenced in the native fungi under our laboratory conditions), the implement of their 299 multiple biosynthetic functions in living cells suggests the promiscuity of these enzymes could organisms preserve their promiscuous activity through evolution to increase fitness for survival 306 because the more products that are generated, the more likely the organism is to produce 307 chemicals with useful biological activity (Fischbach and Clardy, 2007) . 308
Our discoveries and combinatorial biosynthesis strategy accelerated the entire process for 309 discovery and creation of terpenoids. We demonstrated that terpene synthases with substrate 310 promiscuity were widespread. Hundreds of protein candidates with similar property existed in 311 current database. In addition, engineering the residues in the binding pocket can be further 312 incorporated to access more scaffolds. Notably, the substrate promiscuity was not unique in 313 di/sesterterpene synthases, which were concentrated in clade III fungal terpene synthases. We 314 focused on this kind of enzymes because they could be utilized to generate relatively complex 315 compounds with one or more rings. The polycyclic skeletons extensive in di-and applications (Stockdale and Williams, 2015) , e.g. diterpenoids Taxol (paclitaxel) used in cancer 318 therapy. Many skeletons, e.g. compound 1, 2, and 56, we produced in this study are precursors of 319 natural products with important pharmaceutical activities (Fig. S4b) . The metabolic engineering 320 platform helps us obtain a sufficient amount of these scaffolds, not only enabling the elucidation 321 of their chemical structures, but also being a start for industrial application. New products can be generated by FgMS mutants. WT, wild-type FgMS. (e) The chemical 485 structure of compound 56.
